HC Wainwright Reiterates Buy Rating on Palisade Bio, Sets $7 Target

HC Wainwright & Co. reiterated its Buy rating on Palisade Bio and a $7.00 price target. The target implies 340.3% upside from the Oct. 12 close of $1.59.